CHICAGO - If two former U.S. presidents shared the stage to talk about the impact of the biotech industry and members of the press were not allowed to attend and report on it, did it really happen? (BioWorld Today - 2010 BIO)
CHICAGO - While attendees at last year's convention in Atlanta were feeling the full brunt of the global economic recession, arrivals at the McCormick Place convention center were greeting this year's Biotechnology Industry Organization meeting with much more optimism, no doubt helped by the mainstream media, which has been posting a flurry of recent stories predicting an economic recovery. (BioWorld Today - 2010 BIO)
Shares of NeuroSearch A/S sank 30 percent when it turned out the firm's positive Phase III Huntington's disease trial was not quite so positive after all. (BioWorld Today)
Impressive, though early stage, Phase I data already has Pluristem Therapeutics Inc. setting the stage for Phase II testing with its placenta-derived cell therapy treatment PLX-PAD in critical limb ischemia. (BioWorld Today)
The FDA granted approval late Friday for Tarceva (erlotinib) as a maintenance therapy for non-small-cell lung cancer patients, a decision that defied a negative 12-to-1 panel vote last year but is likely to offer only a modest boost to sales of the drug from OSI Pharmaceuticals Inc. and Genentech Inc./Roche AG. (BioWorld Today)
